Can gauze be applied to stop bleeding during the management of postpartum hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Gauze Packing for Postpartum Hemorrhage: Not Recommended as First-Line

Intrauterine balloon tamponade should be used instead of gauze packing for refractory postpartum hemorrhage, as gauze packing probably increases postpartum anemia and maternal fever without clear benefit. 1

Evidence-Based Management Algorithm

The WHO guidelines clearly establish the standard treatment package for PPH, which includes fluid replacement, uterotonics, monitoring, and non-surgical interventions (bimanual compression, intrauterine balloon tamponade, non-pneumatic antishock garment, external aortic compression) before moving to surgical interventions 2. Notably, gauze packing is not mentioned in these contemporary WHO recommendations.

Why Balloon Tamponade Over Gauze

The most recent high-quality evidence from 2026 demonstrates that:

  • Moderate-certainty evidence shows gauze packing increases postpartum anemia (RR 1.27,95% CI 1.07-1.51) and maternal fever >38°C (RR 2.40,95% CI 1.21-4.76) compared to balloon tamponade 1
  • Gauze packing does not reduce the need for additional surgical interventions or blood transfusions 1
  • Balloon tamponade reduces blood loss volume (mean difference -276.2 mL), likely reduces transfusion requirements, and significantly reduces organ injury (RR 0.65) and infection (RR 0.47) compared to gauze 3

When Gauze Might Be Considered

While the evidence strongly favors balloon tamponade, gauze packing may have a role in specific circumstances:

  • Chitosan-covered gauze (not plain gauze) showed promise in a 2013 study, reducing peripartum hysterectomy rates by 75% 4
  • Resource-limited settings where balloon tamponade is unavailable 4
  • After cesarean delivery through the hysterotomy or transvaginally for up to 24 hours 4

Critical Timing Considerations

The evidence emphasizes that tranexamic acid must be given within 3 hours of birth as part of the standard PPH package, with benefit decreasing 10% for every 15-minute delay 2. This pharmacologic intervention takes priority over mechanical interventions like gauze packing.

Common Pitfalls to Avoid

  1. Using plain gauze instead of balloon tamponade when both are available—this increases infection risk and anemia without improving outcomes
  2. Delaying tranexamic acid administration while attempting mechanical interventions
  3. Skipping less invasive measures (bimanual compression, external aortic compression) and jumping directly to gauze packing
  4. Leaving gauze in place beyond 24 hours, which increases infection risk

The Bottom Line

Start with tranexamic acid (1g IV over 10 minutes, repeat in 30 minutes if needed) plus uterotonics, then proceed to balloon tamponade if bleeding continues. Reserve gauze packing only for situations where balloon tamponade is unavailable or has failed, and preferably use chitosan-covered gauze rather than plain gauze if available. The sequential approach should always move from less invasive to more invasive interventions 2.

References

Research

Intrauterine balloon tamponade versus uterine gauze packing for postpartum hemorrhage: A systematic review and meta-analysis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026

Research

Uterine packing with chitosan-covered gauze for control of postpartum hemorrhage.

American journal of obstetrics and gynecology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.